CStone Pharmaceuticals

CSPHF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$387,937$996,671$558,684$742,724
Short-Term Investments$285,000$51,850$483,407$983,615
Receivables$130,875$172,438$77,133$117,598
Inventory$286,096$108,828$22,188$61,363
Other Curr. Assets$0$0$105,505$52,345
Total Curr. Assets$1,089,908$1,329,787$1,246,917$1,957,645
Property Plant & Equip (Net)$130,543$153,368$206,566$187,923
Goodwill$0$0$0$0
Intangibles$161,366$173,045$159,699$70,539
Long-Term Investments-$275,968$3,541-$479,925-$980,427
Tax Assets$0$0$479,925$0
Other NC Assets$287,617$2,258$25,245$1,035,773
Total NC Assets$303,558$332,212$391,510$313,808
Other Assets$0$0$0$0
Total Assets$1,393,466$1,661,999$1,638,427$2,271,453
Liabilities
Payables$338,029$246,377$290,414$414,293
Short-Term Debt$93,216$139,313$44,918$43,948
Tax Payable$1,774$17,660$5,819$24,288
Deferred Revenue$0$0$0$0
Other Curr. Liab.$248,987$446,988$605,331$450,419
Total Curr. Liab.$682,006$850,338$946,482$932,948
LT Debt$262,757$224,135$241,372$130,250
Deferred Rev, NC$84,832$61,967$1,247$1,247
Deferred Tax Liab, NC$0$0$0-$1,247
Other NC Liab.$0$68,729$0$1,247
Total NC Liab.$347,589$354,831$242,619$131,497
Other Liabilities$0$0$0$0
Cap. Leases$37,773$44,462$58,737$27,687
Total Liabilities$1,029,595$1,205,169$1,189,101$1,064,445
Equity
Pref Stock$0$0$0$0
Common Stock$860$860$802$796
Retained Earnings-$9,110,934-$9,019,727-$8,652,493-$7,749,815
AOCI$469,993$483,246$473,087$491,436
Other Equity$9,003,952$8,992,451$8,627,930$8,464,591
Total Equity$363,871$456,830$449,326$1,207,008
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,393,466$1,661,999$1,638,427$2,271,453
Net Debt-$31,964-$633,223-$272,394-$568,526